Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12127523rdf:typepubmed:Citationlld:pubmed
pubmed-article:12127523lifeskim:mentionsumls-concept:C0209606lld:lifeskim
pubmed-article:12127523lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:12127523pubmed:issue16lld:pubmed
pubmed-article:12127523pubmed:dateCreated2002-7-19lld:pubmed
pubmed-article:12127523pubmed:abstractTextA series of potent N-(aralkyl-, arylcycloalkyl-, and heteroaryl-acyl)-4-biphenylalanine VLA-4 antagonists was prepared by rapid analogue methods using solid-phase chemistry. Further optimization led to several highly potent compounds (IC(50) <1 nM). Evaluation of rat pharmacokinetic revealed generally high clearance.lld:pubmed
pubmed-article:12127523pubmed:languageenglld:pubmed
pubmed-article:12127523pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12127523pubmed:citationSubsetIMlld:pubmed
pubmed-article:12127523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12127523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12127523pubmed:statusMEDLINElld:pubmed
pubmed-article:12127523pubmed:monthAuglld:pubmed
pubmed-article:12127523pubmed:issn0960-894Xlld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:LanzaThomasTJ...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:MumfordRichar...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:SchmidtJohn...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:MacCossMalcol...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:HagmannWillia...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:KameneckaTheo...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:KopkaIhor EIElld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:DurettePhilip...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:TongSharonSlld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:LiBingBlld:pubmed
pubmed-article:12127523pubmed:authorpubmed-author:McCauleyErmen...lld:pubmed
pubmed-article:12127523pubmed:issnTypePrintlld:pubmed
pubmed-article:12127523pubmed:day19lld:pubmed
pubmed-article:12127523pubmed:volume12lld:pubmed
pubmed-article:12127523pubmed:ownerNLMlld:pubmed
pubmed-article:12127523pubmed:authorsCompleteYlld:pubmed
pubmed-article:12127523pubmed:pagination2141-4lld:pubmed
pubmed-article:12127523pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:meshHeadingpubmed-meshheading:12127523...lld:pubmed
pubmed-article:12127523pubmed:year2002lld:pubmed
pubmed-article:12127523pubmed:articleTitleN-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists.lld:pubmed
pubmed-article:12127523pubmed:affiliationDepartment of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. bing_li@merck.comlld:pubmed
pubmed-article:12127523pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12127523lld:chembl